BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8771673)

  • 41. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A; Hill GS; Montseny JJ; Meyrier A
    Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Problems of clinical and morphological classification and observation of the course of glomerulonephritis. Initial results in long-term therapy].
    Krumhaar I; Reinschke P; Peschel HG; Otto F; Schwedtke H
    Dtsch Gesundheitsw; 1971 Feb; 26(8):333-41. PubMed ID: 5576672
    [No Abstract]   [Full Text] [Related]  

  • 43. [Urine excretion of a monocytic chemotaxic protein-1 and a transforming growth factor beta1 as an indicator of chronic glomerulonephritis progression].
    Bobkova IN; Chebotareva NV; Kozlovskaia LV; Varshavskiĭ VA; Golitsyna EP
    Ter Arkh; 2006; 78(5):9-14. PubMed ID: 16889042
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Polymorphism studies of angiotensin converting enzyme gene in chronic glomerulonephritis].
    Kutyrina IM; Tareeva IE; Nosikov VV; Kamyshova ES; Gorashko NM; Chistiakov DA; Okonova EB; Troepol'skaia OV
    Ter Arkh; 1999; 71(6):30-4. PubMed ID: 10420452
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Histological classification of chronic glomerular diseases].
    Noël LH; Gubler MC
    Rev Prat; 2003 Nov; 53(18):2005-12. PubMed ID: 15008214
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Primary mesangiocapillary glomerulonephritis].
    Diadyk AI; Vasilenko IV; Shpilevaia NI; Iarovaia NF; Siniachenko OV
    Arkh Patol; 1987; 49(9):81-5. PubMed ID: 3318766
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Systemic enzyme therapy in chronic glomerulonephritis].
    Siniachenko OV; Kovalenko VN; Mukhin IV; Ignatenko GA; Terzov AI
    Ter Arkh; 2000; 72(2):46-8. PubMed ID: 10717926
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparison of two cyclophosphamide treatment regimens in nephrotic patients with chronic glomerulonephritis].
    Krasnova TN; Shilov EM; Tareeva IE; Gordovskaia NB; Lavrova ON; Miroshnichenko NG; Troepol'skaia OV; Ivanova LV; Ivanov AA
    Ter Arkh; 1998; 70(6):14-7. PubMed ID: 9695216
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Chronic glomerulonephritis and pregnancy].
    Rogov VA; Shilov EM; Kozlovskaia NL; Gordovskaia NB; Nikiforova OV; Makarov OI; Milovanov AP
    Ter Arkh; 2004; 76(9):21-6. PubMed ID: 15532371
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A course of chronic glomerulonephritis and constitutional features].
    Kukhtevich AV; Kulikova EV; Zilov VG
    Ter Arkh; 2003; 75(6):37-40. PubMed ID: 12920957
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Features of a cytokine profile in patients with chronic glomerulonephritis with progressive chronic renal failure].
    Koriakova NN; Rozhdestvenskaia ED; Kazantseva SV; Bushueva TV; Valamina IE
    Ter Arkh; 2006; 78(5):14-7. PubMed ID: 16889043
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatitis-B virus associated nephropathies: a clinicopathological study in 14 children.
    Ozdamar SO; Gucer S; Tinaztepe K
    Pediatr Nephrol; 2003 Jan; 18(1):23-8. PubMed ID: 12488986
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
    Duman VL; Shkerina LI; Shilov EM
    Klin Med (Mosk); 2005; 83(10):48-50. PubMed ID: 16320847
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical course and prognosis in various morphological forms of chronic glomerulonephritis].
    Tareeva IE; Serov VV; Varshavskiĭ VA; Kaliev R
    Ter Arkh; 1981; 53(6):10-4. PubMed ID: 7281019
    [No Abstract]   [Full Text] [Related]  

  • 55. Rapidly progressive glomerulonephritis.
    Bolton WK
    Semin Nephrol; 1996 Nov; 16(6):517-26. PubMed ID: 9125796
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New classification of diffuse glomerulonephritis based on prognosis, especially new proposal of subchronic glomerulonephritis.
    Kinoshita Y; Fujisaki S; Watabe Y; Mikami A; Yamada A; Hirasawa Y; Osawa G; Takahashi G; Morita T
    Acta Med Biol (Niigata); 1966 Jun; 14(1):35-49. PubMed ID: 5925781
    [No Abstract]   [Full Text] [Related]  

  • 57. [Glomerulonephritis. III. Characteristics of morphological types according to WHO classification].
    Kruś S; Domagała J
    Pol Arch Med Wewn; 1980 Jun; 63(6):565-79. PubMed ID: 6995952
    [No Abstract]   [Full Text] [Related]  

  • 58. [Urinary excretion of glycosaminoglycans in patients with chronic pyelonephritis and chronic glomerulonephritis].
    Pavlov SB
    Klin Med (Mosk); 1998; 76(2):41-3. PubMed ID: 9553361
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Early diagnosis and treatment of chronic glomerulonephritis].
    Kinoshita Y; Osawa G; Mikami A; Morita T; Kobayashi N
    Naika; 1969 Jun; 23(6):1190-201. PubMed ID: 5805493
    [No Abstract]   [Full Text] [Related]  

  • 60. [Morphological classification of glomerulonephritis (continuation)].
    Ditscherlein G
    Z Gesamte Inn Med; 1980 Sep; 35(17):Suppl 65-6. PubMed ID: 7467585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.